Zogenix is a California-based biopharmaceutical company that develops and commercializes transformative therapies for the treatment of epilepsy and mitochondrial diseases.
Read moreFounded
2006
Headquarters
Website
Annual Revenue
$81.7M
Zogenix's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 452.5M. Over the last four quarters, Zogenix's revenue has grown by 94.4%. Specifically, in Q4 2021's revenue was $26.6M; in Q3 2021, it was $22.6M; in Q2 2021, it was $18.8M; in Q1 2021, Zogenix's revenue was $13.7M.